103 related articles for article (PubMed ID: 23911936)
1. Regulator of G protein signaling 19 suppresses Ras-induced neoplastic transformation and tumorigenesis.
Wang Y; Tong Y; Tso PH; Wong YH
Cancer Lett; 2013 Oct; 339(1):33-41. PubMed ID: 23911936
[TBL] [Abstract][Full Text] [Related]
2. RGS19 inhibits Ras signaling through Nm23H1/2-mediated phosphorylation of the kinase suppressor of Ras.
Tso PH; Wang Y; Yung LY; Tong Y; Lee MM; Wong YH
Cell Signal; 2013 May; 25(5):1064-74. PubMed ID: 23416464
[TBL] [Abstract][Full Text] [Related]
3. Metastasis suppressors Nm23H1 and Nm23H2 differentially regulate neoplastic transformation and tumorigenesis.
Tong Y; Yung LY; Wong YH
Cancer Lett; 2015 Jun; 361(2):207-17. PubMed ID: 25748386
[TBL] [Abstract][Full Text] [Related]
4. RGS19 enhances cell proliferation through its C-terminal PDZ motif.
Tso PH; Wang Y; Wong SY; Poon LS; Chan AS; Wong YH
Cell Signal; 2010 Nov; 22(11):1700-7. PubMed ID: 20599498
[TBL] [Abstract][Full Text] [Related]
5. Effect of Ha-rasval12 on nm23 expression, tumor formation and metastasis of the transformants, and immunomodulation in tumor-bearing mice.
Hsieh CC; Wu SY; Lan SH; Weng TY; Tsai Y; Liu HS
Anticancer Res; 2010 Sep; 30(9):3585-92. PubMed ID: 20944141
[TBL] [Abstract][Full Text] [Related]
6. The downregulation of the pro-apoptotic protein Par-4 is critical for Ras-induced survival and tumor progression.
Barradas M; Monjas A; Diaz-Meco MT; Serrano M; Moscat J
EMBO J; 1999 Nov; 18(22):6362-9. PubMed ID: 10562548
[TBL] [Abstract][Full Text] [Related]
7. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.
Rusyn EV; Reynolds ER; Shao H; Grana TM; Chan TO; Andres DA; Cox AD
Oncogene; 2000 Sep; 19(41):4685-94. PubMed ID: 11032018
[TBL] [Abstract][Full Text] [Related]
8. Ras-related tumorigenesis is suppressed by BNIP3-mediated autophagy through inhibition of cell proliferation.
Wu SY; Lan SH; Cheng DE; Chen WK; Shen CH; Lee YR; Zuchini R; Liu HS
Neoplasia; 2011 Dec; 13(12):1171-82. PubMed ID: 22241963
[TBL] [Abstract][Full Text] [Related]
9. Geranylgeranylated, but not farnesylated, RhoB suppresses Ras transformation of NIH-3T3 cells.
Mazières J; Tillement V; Allal C; Clanet C; Bobin L; Chen Z; Sebti SM; Favre G; Pradines A
Exp Cell Res; 2005 Apr; 304(2):354-64. PubMed ID: 15748883
[TBL] [Abstract][Full Text] [Related]
10. Antisense DNA inhibition of tumor growth induced by c-Ha-ras oncogene in nude mice.
Gray GD; Hernandez OM; Hebel D; Root M; Pow-Sang JM; Wickstrom E
Cancer Res; 1993 Feb; 53(3):577-80. PubMed ID: 8425190
[TBL] [Abstract][Full Text] [Related]
11. RACK1 regulates Ki-Ras-mediated signaling and morphological transformation of NIH 3T3 cells.
Bjørndal B; Myklebust LM; Rosendal KR; Myromslien FD; Lorens JB; Nolan G; Bruland O; Lillehaug JR
Int J Cancer; 2007 Mar; 120(5):961-9. PubMed ID: 17149700
[TBL] [Abstract][Full Text] [Related]
12. H-ras and raf-1 cooperate in transformation of NIH3T3 fibroblasts.
Cuadrado A; Bruder JT; Heidaran MA; App H; Rapp UR; Aaronson SA
Oncogene; 1993 Sep; 8(9):2443-8. PubMed ID: 8361757
[TBL] [Abstract][Full Text] [Related]
13. NM23H2 inhibits EGF- and Ras-induced proliferation of NIH3T3 cells by blocking the ERK pathway.
Lee MY; Jeong WJ; Oh JW; Choi KY
Cancer Lett; 2009 Mar; 275(2):221-6. PubMed ID: 19022560
[TBL] [Abstract][Full Text] [Related]
14. The retinoblastoma protein is required for Ras-induced oncogenic transformation.
Williams JP; Stewart T; Li B; Mulloy R; Dimova D; Classon M
Mol Cell Biol; 2006 Feb; 26(4):1170-82. PubMed ID: 16449633
[TBL] [Abstract][Full Text] [Related]
15. RGS6 suppresses Ras-induced cellular transformation by facilitating Tip60-mediated Dnmt1 degradation and promoting apoptosis.
Huang J; Stewart A; Maity B; Hagen J; Fagan RL; Yang J; Quelle DE; Brenner C; Fisher RA
Oncogene; 2014 Jul; 33(27):3604-11. PubMed ID: 23995786
[TBL] [Abstract][Full Text] [Related]
16. Analysis of Ras-induced oncogenic transformation of NIH-3T3 cells using differential-display 2-DE proteomics.
Ji H; Moritz RL; Kim YS; Zhu HJ; Simpson RJ
Electrophoresis; 2007 Jun; 28(12):1997-2008. PubMed ID: 17526045
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor-β-stimulated clone-22 is a negative-feedback regulator of Ras / Raf signaling: Implications for tumorigenesis.
Nakamura M; Kitaura J; Enomoto Y; Lu Y; Nishimura K; Isobe M; Ozaki K; Komeno Y; Nakahara F; Oki T; Kume H; Homma Y; Kitamura T
Cancer Sci; 2012 Jan; 103(1):26-33. PubMed ID: 21943131
[TBL] [Abstract][Full Text] [Related]
18. RGS19 converts iron deprivation stress into a growth-inhibitory signal.
Hwang J; Kim HS; Kang BS; Kim DH; Ryoo ZY; Choi SU; Lee S
Biochem Biophys Res Commun; 2015 Aug; 464(1):168-75. PubMed ID: 26116529
[TBL] [Abstract][Full Text] [Related]
19. Reduction in the requirement of oncogenic Ras signaling to activation of PI3K/AKT pathway during tumor maintenance.
Lim KH; Counter CM
Cancer Cell; 2005 Nov; 8(5):381-92. PubMed ID: 16286246
[TBL] [Abstract][Full Text] [Related]
20. Cystine/glutamate antiporter xCT (SLC7A11) facilitates oncogenic RAS transformation by preserving intracellular redox balance.
Lim JKM; Delaidelli A; Minaker SW; Zhang HF; Colovic M; Yang H; Negri GL; von Karstedt S; Lockwood WW; Schaffer P; Leprivier G; Sorensen PH
Proc Natl Acad Sci U S A; 2019 May; 116(19):9433-9442. PubMed ID: 31000598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
